Literature DB >> 21388871

Clinical manifestations in individuals with recent diagnosis of HTLV type I infection.

Shelene K W Poetker1, Aurelia F Porto, Silvana P Giozza, Andre L Muniz, Marina F Caskey, Edgar M Carvalho, Marshall J Glesby.   

Abstract

BACKGROUND: Human T-lymphotropic virus type 1 (HTLV-1) is known to cause HTLV-associated myelopathy (HAM)/tropical spastic paraparesis and adult T cell leukemia. A growing body of evidence links HTLV-1 infection with an increasing spectrum of disease, including uveitis, periodontal disease, arthropathy, sicca syndrome, and neurologic deficits.
OBJECTIVES: Despite recent findings, the natural history of HTLV-1 infection remains poorly defined. This study was designed to better characterize initial clinical and neurological findings in individuals diagnosed with HTLV-1 infection. STUDY
DESIGN: We conducted a cross-sectional study of 71 individuals recently diagnosed with HTLV-1 and 71 uninfected age- and sex-matched blood donors in Salvador, Brazil. Subjects were administered a standardized questionnaire and underwent physical exam.
RESULTS: HTLV-1 infected subjects were significantly more likely than controls to report complaints of hand and foot numbness (OR=5.3; 95% CI: 1.8-15.3; p=0.002 and OR=4.0; 95% CI: 1.3-12; p=0.013 respectively), difficulty running (OR=4.0; 95% CI: 1.1-14.2; p=0.032), nocturia (OR=5.0; 95% CI: 1.1-22.8; p=0.038), arthralgia (OR=3.3; 95% CI: 1.4-7.7; p=0.006), and photophobia (OR=3.3; 95% CI: 1.4-7.7; p=0.006).
CONCLUSIONS: Neurologic, ocular and rheumatologic complaints may be the first manifestations of HTLV-1 infection. Therefore, all patients presenting with initial diagnosis should be rigorously screened for these symptoms.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21388871      PMCID: PMC3074002          DOI: 10.1016/j.jcv.2011.02.004

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  40 in total

1.  HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics.

Authors:  Inês Dourado; Luiz C J Alcantara; Maurício L Barreto; Maria da Gloria Teixeira; Bernardo Galvão-Castro
Journal:  J Acquir Immune Defic Syndr       Date:  2003-12-15       Impact factor: 3.731

2.  Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors.

Authors:  E M Carvalho; O Bacellar; A F Porto; S Braga; B Galvão-Castro; F Neva
Journal:  J Acquir Immune Defic Syndr       Date:  2001-05-01       Impact factor: 3.731

3.  Clinical features of human T-lymphotropic virus type 1 uveitis: a long-term follow-up.

Authors:  T Takahashi; H Takase; T Urano; S Sugita; K Miyata; N Miyata; M Mochizuki
Journal:  Ocul Immunol Inflamm       Date:  2000-12       Impact factor: 3.070

Review 4.  Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease.

Authors:  Steven Jacobson
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

5.  HTLV-I/II prevalence in different geographic locations.

Authors:  Hans Vrielink; Henk W Reesink
Journal:  Transfus Med Rev       Date:  2004-01

6.  Neurological manifestations in HTLV-I-infected blood donors.

Authors:  Ana C C Leite; Gulnar A S Mendonça; Maria José Andrada Serpa; Osvaldo J M Nascimento; Abelardo Q-C Araújo
Journal:  J Neurol Sci       Date:  2003-10-15       Impact factor: 3.181

7.  Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study.

Authors:  J R Orland; J Engstrom; J Fridey; R A Sacher; J W Smith; C Nass; G Garratty; B Newman; D Smith; B Wang; K Loughlin; E L Murphy
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

8.  Dermatologic lesions in asymptomatic blood donors seropositive for human T cell lymphotropic virus type-1.

Authors:  Denise Utsch Gonçalves; Antônio Carlos Martins Guedes; Anna Bárbara de Freitas Carneiro Proietti; Marina Lobato Martins; Fernando Augusto Proietti; José Roberto Lambertucci
Journal:  Am J Trop Med Hyg       Date:  2003-05       Impact factor: 2.345

Review 9.  Ocular manifestations of human T-cell lymphotropic virus type 1 infection.

Authors:  Ronald R Buggage
Journal:  Curr Opin Ophthalmol       Date:  2003-12       Impact factor: 3.761

10.  Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection.

Authors:  Edward L Murphy; Baoguang Wang; Ronald A Sacher; Joy Fridey; James W Smith; Catharie C Nass; Bruce Newman; Helen E Ownby; George Garratty; Shelia T Hutching; George B Schreiber
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

View more
  23 in total

1.  Effects of Physiotherapy in the Treatment of Neurogenic Bladder in Patients Infected With Human T-Lymphotropic Virus 1.

Authors:  Rosana C P Andrade; José A Neto; Luciana Andrade; Tatiane S Oliveira; Dislene N Santos; Cassius J V Oliveira; Márcio J Prado; Edgar M Carvalho
Journal:  Urology       Date:  2015-12-24       Impact factor: 2.649

2.  Soluble IL-2 receptor and beta-2 microglobulin as possible serologic markers of neurologic disease in HTLV-1 infection.

Authors:  Cristina Toledo-Cornell; Silvane Santos; Gloria Orge; Marshall J Glesby; Edgar M Carvalho
Journal:  J Med Virol       Date:  2013-09-11       Impact factor: 2.327

3.  Dermatological manifestations of individuals infected with human T cell lymphotropic virus type I (HTLV-I).

Authors:  Lorena Dantas; Eduardo Netto; Marshall J Glesby; Edgar M Carvalho; Paulo Machado
Journal:  Int J Dermatol       Date:  2013-09-30       Impact factor: 2.736

4.  Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Infected Individuals Without HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study.

Authors:  Davi Tanajura; Néviton Castro; Paulo Oliveira; Abraão Neto; André Muniz; Natália B Carvalho; Glória Orge; Silvane Santos; Marshall J Glesby; Edgar M Carvalho
Journal:  Clin Infect Dis       Date:  2015-03-27       Impact factor: 9.079

5.  Neurological manifestations in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis in the Amazon.

Authors:  G A S Dias; G T Yoshikawa; R V L Koyama; S Fujihara; L C S Martins; R Medeiros; J A S Quaresma; H T Fuzii
Journal:  Spinal Cord       Date:  2015-07-14       Impact factor: 2.772

6.  Incomplete myelopathy and human T cell lymphotropic virus type-1 (HTLV-1).

Authors:  Roberta Vilela Lopes Koyama; Gilberto Toshimitsu Yoshikawa; Satomi Fujihara; George Alberto da Silva Dias; Rodrigo Rodrigues Virgolino; Anderson Raiol Rodrigues; Rita Medeiros; Juarez Antônio Simões Quaresma; Hellen Thaís Fuzii
Journal:  J Neurovirol       Date:  2018-10-05       Impact factor: 2.643

7.  Psychiatric Disorders in HTLV-1-Infected Individuals with Bladder Symptoms.

Authors:  Glória O Orge; Thais R Dellavechia; José Abraão Carneiro-Neto; Lucas Araújo-de-Freitas; Carla H C Daltro; Carlos T Santos; Lucas C Quarantini
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

8.  HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways.

Authors:  Robert Currer; Rachel Van Duyne; Elizabeth Jaworski; Irene Guendel; Gavin Sampey; Ravi Das; Aarthi Narayanan; Fatah Kashanchi
Journal:  Front Microbiol       Date:  2012-11-30       Impact factor: 5.640

9.  HTLV-1 uveitis.

Authors:  Koju Kamoi; Manabu Mochizuki
Journal:  Front Microbiol       Date:  2012-07-24       Impact factor: 5.640

10.  Human T-lymphotropic Virus Type I (HTLV-I) Proviral Load and Clinical Features in Iranian HAM/TSP Patients: Comparison of HTLV-I Proviral Load in HAM/TSP Patients.

Authors:  Rosita Vakili; Faezeh Sabet; Sanaz Aahmadi; Reza Boostani; Houshang Rafatpanah; Ali Shamsian; S A Rahim Rezaee
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.